SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-060182
Filing Date
2018-10-03
Accepted
2018-10-03 08:00:26
Documents
4
Period of Report
2018-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-36261_28k.htm 8-K 31695
2 EX-1.1 a18-36261_2ex1d1.htm EX-1.1 248503
3 EX-5.1 a18-36261_2ex5d1.htm EX-5.1 14527
4 GRAPHIC g362612kii001.jpg GRAPHIC 2502
  Complete submission text file 0001104659-18-060182.txt   299580
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

IRS No.: 481293684 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-33818 | Film No.: 181103708
SIC: 3845 Electromedical & Electrotherapeutic Apparatus